Molecular Playground/Human Galactosamine-6-sulfatase

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
One of the [[CBI Molecules]] being studied in the [http://www.umass.edu/cbi/ University of Massachusetts Amherst Chemistry-Biology Interface Program] at UMass Amherst and on display at the [http://www.molecularplayground.org/ Molecular Playground].
One of the [[CBI Molecules]] being studied in the [http://www.umass.edu/cbi/ University of Massachusetts Amherst Chemistry-Biology Interface Program] at UMass Amherst and on display at the [http://www.molecularplayground.org/ Molecular Playground].
-
===Human Lysosomal Protective Protein Cathepsin A (PPCA)===
+
===Human galactosamine-6-sulfatase (GALNS)===
-
[[Image:PPCA.jpg|frame|Human Lysosomal Protective Protein Cathepsin A]]
+
[[Image:GALNS.jpg|frame|Human N-acetyl-galactosamine-6-sulfatase]]
-
The human protective protein cathepsin A forms a multi-enzyme complex with beta-galactosidase and neuraminidase in lysosomes. PPCA has so far two functions:a catalytic activity overlapping with that of Cathepsin A and a protective function towards lysosomal beta-galactosidase and neuraminidase. The stability and activity of the latter glycosidases depend on their interaction with PPCA [1].
+
The human lysosomal galactosamine-6-sulfatase (E.C. 3.1.6.4), also known as N-acetylgalactosamine-6-sulfatase, removes sulfate groups from a terminal N-acetyl-galactose-6-sulfate (or galactose-6-sulfate) in mucopolysaccharides such as keratan sulfate and chondroitin-6-sulfate Defects in GALNS lead to accumulation of mucopolysaccharides, resulting in the development of the lysosomal storage disease mucopolysaccharidosis 4A (also known as Morquio A disease[1].
{{Clear}}
{{Clear}}
-
<applet load='1ivy' size='[450,338]' frame='true' align='right'
+
<applet load='4FDJ' size='[450,338]' frame='true' align='right'
-
caption='Human Lysosomal Protective Protein Cathepsin A (1ivy)' scene=''User:Yadilette_Rivera-Colon/Sandbox1/Loadedfrompdb/4'/>
+
caption='human lysosomal galactosamine-6-sulfatase (4FDI)' scene=''User:Yadilette_Rivera-Colon/Sandbox1/Loadedfrompdb/4'/>
-
=== PPCA Glycosylation sites ===
+
=== GALNS active site ===
-
PPCA, is synthesized as a 542 amino acid precursor with a molecular weight of 54kDa. and it dimerizes soon after synthesis. The sequence contains two glycosylation sites, Asn 117 and Asn 305. It also contains nine cysteines. The spinning protein (<scene name='User:Yadilette_Rivera-Colon/Sandbox1/Glycosylation_sites_ppca/1'>PPCA Glycosylation sites</scene> ) is human protective protein with the glycosylation sites represented in stick model colored by atom.
+
Sulfatases require maturation of a side chain residue into a catalytic nucleophile. In GALNS, the polypeptide chain encodes a cysteine at residue 79 at the start of the motif CXPXRXXL. The formylglycine generating enzyme recognizes this motif and converts Cys79 into a formylglycine aldehyde. Hydration of the aldehyde by a water molecule generates the gem diol nucleophile dihydroxyalanine, which ligates Ca2+ in the active site. The spinning protein (<scene name='User:Yadilette_Rivera-Colon/Sandbox1/GALNS_active_site/1'>GALNS active site</scene> ) is human human lysosomal galactosamine-6-sulfatase with GalNac in the active site represented by stick.
==Additional Resources==
==Additional Resources==
Line 19: Line 19:
===References: ===
===References: ===
-
[1] Jackman, H. L., Morris, P. W., Deddish, P. A., Skidgel, R. A. and Erdos, E. G. (1992) J. Biol. Chem. 267, 2872-2875
+
[1]Muenzer, J. Neufeld, E.F. The Mucopolysaccharidoses: In The Metabolic Basis of Inherited Disease, 8th ed. McGraw-Hill: Medical Publishing Division, 2001; Vol. 3 p 3431-3452.
-
Molecular Playground banner: Lysosomal Human Protective Protein Cathepsin A, a lysosomal chaperone, Nobody chaperones the chaperone. That's why it is so right for this job.
+
Molecular Playground banner: Human lysosomal galactosamine-6-sulfatase

Revision as of 17:51, 18 September 2012

One of the CBI Molecules being studied in the University of Massachusetts Amherst Chemistry-Biology Interface Program at UMass Amherst and on display at the Molecular Playground.

Contents

Human galactosamine-6-sulfatase (GALNS)

Human N-acetyl-galactosamine-6-sulfatase
Human N-acetyl-galactosamine-6-sulfatase

The human lysosomal galactosamine-6-sulfatase (E.C. 3.1.6.4), also known as N-acetylgalactosamine-6-sulfatase, removes sulfate groups from a terminal N-acetyl-galactose-6-sulfate (or galactose-6-sulfate) in mucopolysaccharides such as keratan sulfate and chondroitin-6-sulfate Defects in GALNS lead to accumulation of mucopolysaccharides, resulting in the development of the lysosomal storage disease mucopolysaccharidosis 4A (also known as Morquio A disease[1].

human lysosomal galactosamine-6-sulfatase (4FDI)

Drag the structure with the mouse to rotate

GALNS active site

Sulfatases require maturation of a side chain residue into a catalytic nucleophile. In GALNS, the polypeptide chain encodes a cysteine at residue 79 at the start of the motif CXPXRXXL. The formylglycine generating enzyme recognizes this motif and converts Cys79 into a formylglycine aldehyde. Hydration of the aldehyde by a water molecule generates the gem diol nucleophile dihydroxyalanine, which ligates Ca2+ in the active site. The spinning protein ( ) is human human lysosomal galactosamine-6-sulfatase with GalNac in the active site represented by stick.

Additional Resources

For additional information, see: Metabolic Disorders

References:

[1]Muenzer, J. Neufeld, E.F. The Mucopolysaccharidoses: In The Metabolic Basis of Inherited Disease, 8th ed. McGraw-Hill: Medical Publishing Division, 2001; Vol. 3 p 3431-3452.


Molecular Playground banner: Human lysosomal galactosamine-6-sulfatase

Retrieved from "http://52.214.119.220/wiki/index.php/Molecular_Playground/Human_Galactosamine-6-sulfatase"
Personal tools